Immune Response Regulation
The interaction of cell surface receptors with secreted cytokines and with one another tightly controls the immune response, and several groups are investigating the mechanisms by which these interactions have regulatory effects. Understanding how specialised cells or anatomical regions, such as vascular endothelial cells or the epidermis, control and guide the immune response is another important area of research.
The pathogenesis of IBD depends on the interaction of effector T cells and APCs. APCs ingest the antigens that support the inflammatory response. Epitope is presented in the context of MHC class II as a result of antigen degradation within proteasomes. The CD4+ T cell and macrophage engage specifically with antigens when MHC classes II and the T-cell receptor (CD3) connect. The T cell must occur, but it is not enough to activate it. Because binding of CD3 to MHC class II without a co-stimulatory signal might result in energy or apoptosis, a second co-stimulatory signal is also required. Co-stimulatory signals of importance include TNF-TNF receptor, CD40-CD40 ligand, and B7-CD28 binding.
Related Conference of Immune Response Regulation
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Immune Response Regulation Conference Speakers
Recommended Sessions
- Cancer
- Cancer Genetics and Cell Biology
- Cancer Immunology & Immunotherapy
- Cancer Pharmacology
- Cellular Adhesion, Migration, and Inflammation
- Clinical Immunology
- Computational Immunology
- Cytokines and Chemokine’s and Their Receptors
- Haematopoiesis and Immune System Development
- Immune Response Regulation
- Immunogenetics of Autoimmunity
- Immunopathogenic Mechanisms
- Lymphocyte Differentiation and Peripheral Maintenance
- Microbial Parasitic and Fungal Immunology
- Mucosal and Regional Immunology
- Radiation Oncology
- Technological Innovations in Immunology
- Therapeutic Approaches to Autoimmunity
- Transplantation Immunology
- Vaccines and Immunotherapy
- Veterinary and Comparative Immunology
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)
